# Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer

> **NCT02384850** · PHASE1 · TERMINATED · sponsor: **GSO Global Clinical Research BV** · enrollment: 10 (actual)

## Conditions studied

- Colorectal Neoplasm

## Interventions

- **DRUG:** Selinexor
- **DRUG:** Oxaliplatin
- **DRUG:** 5-FU
- **DRUG:** Folinic Acid

## Key facts

- **NCT ID:** NCT02384850
- **Lead sponsor:** GSO Global Clinical Research BV
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-03-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02384850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02384850, "Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02384850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*